Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8951 |
High Similarity |
NPD7266 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.811 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7823 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD37 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7764 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7722 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7661 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD1613 |
Approved |
0.755 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7381 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7268 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD228 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7067 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7013 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6993 |
Remote Similarity |
NPD9494 |
Approved |
0.6993 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6966 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1933 |
Approved |
0.6943 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8151 |
Discontinued |
0.691 |
Remote Similarity |
NPD7038 |
Approved |
0.691 |
Remote Similarity |
NPD7039 |
Approved |
0.6899 |
Remote Similarity |
NPD6653 |
Approved |
0.6899 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6897 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6886 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6883 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD5402 |
Approved |
0.6879 |
Remote Similarity |
NPD3134 |
Approved |
0.6875 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6859 |
Remote Similarity |
NPD3764 |
Approved |
0.6852 |
Remote Similarity |
NPD4237 |
Approved |
0.6852 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6835 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6835 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6835 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD5762 |
Approved |
0.6832 |
Remote Similarity |
NPD5763 |
Approved |
0.6828 |
Remote Similarity |
NPD7843 |
Approved |
0.6826 |
Remote Similarity |
NPD3686 |
Approved |
0.6826 |
Remote Similarity |
NPD3687 |
Approved |
0.6824 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD7819 |
Suspended |
0.6821 |
Remote Similarity |
NPD5494 |
Approved |
0.6813 |
Remote Similarity |
NPD5588 |
Approved |
0.681 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.681 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD7411 |
Suspended |
0.6805 |
Remote Similarity |
NPD6386 |
Approved |
0.6805 |
Remote Similarity |
NPD6385 |
Approved |
0.6802 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.68 |
Remote Similarity |
NPD5126 |
Approved |
0.6788 |
Remote Similarity |
NPD1511 |
Approved |
0.6784 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6841 |
Approved |
0.6776 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6776 |
Remote Similarity |
NPD6842 |
Approved |
0.6772 |
Remote Similarity |
NPD4140 |
Approved |
0.6772 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.677 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6766 |
Remote Similarity |
NPD5403 |
Approved |
0.6759 |
Remote Similarity |
NPD969 |
Suspended |
0.6755 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6754 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6752 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD4536 |
Approved |
0.675 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD4538 |
Approved |
0.675 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD3060 |
Approved |
0.6748 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD3787 |
Discontinued |
0.673 |
Remote Similarity |
NPD447 |
Suspended |
0.6721 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6712 |
Remote Similarity |
NPD5535 |
Approved |
0.6711 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6708 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6707 |
Remote Similarity |
NPD6273 |
Approved |
0.6707 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD1512 |
Approved |
0.6689 |
Remote Similarity |
NPD7157 |
Approved |
0.6688 |
Remote Similarity |
NPD3225 |
Approved |
0.6686 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD5353 |
Approved |
0.6685 |
Remote Similarity |
NPD7906 |
Approved |
0.6684 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6684 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6647 |
Remote Similarity |
NPD5401 |
Approved |
0.6633 |
Remote Similarity |
NPD7874 |
Approved |
0.6633 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6632 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6628 |
Remote Similarity |
NPD5772 |
Approved |
0.6628 |
Remote Similarity |
NPD5773 |
Approved |
0.6626 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6626 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD5735 |
Approved |
0.6621 |
Remote Similarity |
NPD3021 |
Approved |
0.6621 |
Remote Similarity |
NPD3022 |
Approved |
0.6615 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6609 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6606 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD3750 |
Approved |
0.6606 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6605 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6604 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6603 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6601 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6598 |
Remote Similarity |
NPD7999 |
Approved |
0.6597 |
Remote Similarity |
NPD6782 |
Approved |
0.6597 |
Remote Similarity |
NPD6779 |
Approved |
0.6597 |
Remote Similarity |
NPD6781 |
Approved |
0.6597 |
Remote Similarity |
NPD6776 |
Approved |
0.6597 |
Remote Similarity |
NPD6778 |
Approved |
0.6597 |
Remote Similarity |
NPD6777 |
Approved |
0.6597
|
Remote Similarity |
NPD6780 |
Approved |